Home > Cardiology > Drug-eluting stents reduce in-stent restenosis, stroke

Drug-eluting stents reduce in-stent restenosis, stroke


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Journal
JAMA Neurology
Reuters Health - 11/01/2022 - Drug-eluting stents may do a better job reducing in-stent restenosis and stroke recurrence compared with bare-metal stents in patients with symptomatic high-grade intracranial atherosclerotic stenosis, a randomized trial conducted in China shows.  "Intracranial atherosclerotic stenosis remains a major cause of acute ischemic stroke despite best medical therapy," Dr. Wengui Yu of the University of California, Irvine, told Reuters Health by email.  "One of the obstacles for intracranial stenting with uncoated stents is the high risk of in-stent restenosis and stroke recurrence," he added. "This study has demonstrated significant bene...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on